Cargando…
Design of Novel Phosphatidylinositol 3-Kinase Inhibitors for Non-Hodgkin’s Lymphoma: Molecular Docking, Molecular Dynamics, and Density Functional Theory Studies on Gold Nanoparticles
Non-Hodgkin’s lymphomas are a diverse collection of lymphoproliferative cancers that are much less predictable than Hodgkin’s lymphomas with a far greater tendency to metastasize to extranodal sites. A quarter of non-Hodgkin’s lymphoma cases develop at extranodal sites and the majority of them invol...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10005307/ https://www.ncbi.nlm.nih.gov/pubmed/36903539 http://dx.doi.org/10.3390/molecules28052289 |
_version_ | 1784905048095981568 |
---|---|
author | Ali, Abdalrahim M. Makki, Alaa A. Ibraheem, Walaa Abdelrahman, Mohammed Osman, Wadah Sherif, Asmaa E. Ashour, Ahmed Ibrahim, Sabrin R. M. Ghazawi, Kholoud F. Samman, Waad A. Alzain, Abdulrahim A. |
author_facet | Ali, Abdalrahim M. Makki, Alaa A. Ibraheem, Walaa Abdelrahman, Mohammed Osman, Wadah Sherif, Asmaa E. Ashour, Ahmed Ibrahim, Sabrin R. M. Ghazawi, Kholoud F. Samman, Waad A. Alzain, Abdulrahim A. |
author_sort | Ali, Abdalrahim M. |
collection | PubMed |
description | Non-Hodgkin’s lymphomas are a diverse collection of lymphoproliferative cancers that are much less predictable than Hodgkin’s lymphomas with a far greater tendency to metastasize to extranodal sites. A quarter of non-Hodgkin’s lymphoma cases develop at extranodal sites and the majority of them involve nodal and extranodal sites. The most common subtypes include follicular lymphoma, chronic/small lymphocytic leukaemia, mantel cell lymphoma, and marginal zone lymphoma. Umbralisib is one of the latest PI3Kδ inhibitors in clinical trials for several hematologic cancer indications. In this study, new umbralisib analogues were designed and docked to the active site of PI3Kδ, the main target of the phosphoinositol-3-kinase/Akt/mammalian target of the rapamycin pathway (PI3K/AKT/mTOR). This study resulted in eleven candidates, with strong binding to PI3Kδ with a docking score between −7.66 and −8.42 Kcal/mol. The docking analysis of ligand–receptor interactions between umbralisib analogues bound to PI3K showed that their interactions were mainly controlled by hydrophobic interactions and, to a lesser extent, by hydrogen bonding. In addition, the MM-GBSA binding free energy was calculated. Analogue 306 showed the highest free energy of binding with −52.22 Kcal/mol. To identify the structural changes and the complexes’ stability of proposed ligands, molecular dynamic simulation was used. Based on this research finding, the best-designed analogue, analogue 306, formed a stable ligand–protein complex. In addition, pharmacokinetics and toxicity analysis using the QikProp tool demonstrated that analogue 306 had good absorption, distribution, metabolism, and excretion properties. Additionally, it has a promising predicted profile in immune toxicity, carcinogenicity, and cytotoxicity. In addition, analogue 306 had stable interactions with gold nanoparticles that have been studied using density functional theory calculations. The best interaction with gold was observed at the oxygen atom number 5 with −29.42 Kcal/mol. Further in vitro and in vivo investigations are recommended to be carried out to verify the anticancer activity of this analogue. |
format | Online Article Text |
id | pubmed-10005307 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-100053072023-03-11 Design of Novel Phosphatidylinositol 3-Kinase Inhibitors for Non-Hodgkin’s Lymphoma: Molecular Docking, Molecular Dynamics, and Density Functional Theory Studies on Gold Nanoparticles Ali, Abdalrahim M. Makki, Alaa A. Ibraheem, Walaa Abdelrahman, Mohammed Osman, Wadah Sherif, Asmaa E. Ashour, Ahmed Ibrahim, Sabrin R. M. Ghazawi, Kholoud F. Samman, Waad A. Alzain, Abdulrahim A. Molecules Article Non-Hodgkin’s lymphomas are a diverse collection of lymphoproliferative cancers that are much less predictable than Hodgkin’s lymphomas with a far greater tendency to metastasize to extranodal sites. A quarter of non-Hodgkin’s lymphoma cases develop at extranodal sites and the majority of them involve nodal and extranodal sites. The most common subtypes include follicular lymphoma, chronic/small lymphocytic leukaemia, mantel cell lymphoma, and marginal zone lymphoma. Umbralisib is one of the latest PI3Kδ inhibitors in clinical trials for several hematologic cancer indications. In this study, new umbralisib analogues were designed and docked to the active site of PI3Kδ, the main target of the phosphoinositol-3-kinase/Akt/mammalian target of the rapamycin pathway (PI3K/AKT/mTOR). This study resulted in eleven candidates, with strong binding to PI3Kδ with a docking score between −7.66 and −8.42 Kcal/mol. The docking analysis of ligand–receptor interactions between umbralisib analogues bound to PI3K showed that their interactions were mainly controlled by hydrophobic interactions and, to a lesser extent, by hydrogen bonding. In addition, the MM-GBSA binding free energy was calculated. Analogue 306 showed the highest free energy of binding with −52.22 Kcal/mol. To identify the structural changes and the complexes’ stability of proposed ligands, molecular dynamic simulation was used. Based on this research finding, the best-designed analogue, analogue 306, formed a stable ligand–protein complex. In addition, pharmacokinetics and toxicity analysis using the QikProp tool demonstrated that analogue 306 had good absorption, distribution, metabolism, and excretion properties. Additionally, it has a promising predicted profile in immune toxicity, carcinogenicity, and cytotoxicity. In addition, analogue 306 had stable interactions with gold nanoparticles that have been studied using density functional theory calculations. The best interaction with gold was observed at the oxygen atom number 5 with −29.42 Kcal/mol. Further in vitro and in vivo investigations are recommended to be carried out to verify the anticancer activity of this analogue. MDPI 2023-03-01 /pmc/articles/PMC10005307/ /pubmed/36903539 http://dx.doi.org/10.3390/molecules28052289 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Ali, Abdalrahim M. Makki, Alaa A. Ibraheem, Walaa Abdelrahman, Mohammed Osman, Wadah Sherif, Asmaa E. Ashour, Ahmed Ibrahim, Sabrin R. M. Ghazawi, Kholoud F. Samman, Waad A. Alzain, Abdulrahim A. Design of Novel Phosphatidylinositol 3-Kinase Inhibitors for Non-Hodgkin’s Lymphoma: Molecular Docking, Molecular Dynamics, and Density Functional Theory Studies on Gold Nanoparticles |
title | Design of Novel Phosphatidylinositol 3-Kinase Inhibitors for Non-Hodgkin’s Lymphoma: Molecular Docking, Molecular Dynamics, and Density Functional Theory Studies on Gold Nanoparticles |
title_full | Design of Novel Phosphatidylinositol 3-Kinase Inhibitors for Non-Hodgkin’s Lymphoma: Molecular Docking, Molecular Dynamics, and Density Functional Theory Studies on Gold Nanoparticles |
title_fullStr | Design of Novel Phosphatidylinositol 3-Kinase Inhibitors for Non-Hodgkin’s Lymphoma: Molecular Docking, Molecular Dynamics, and Density Functional Theory Studies on Gold Nanoparticles |
title_full_unstemmed | Design of Novel Phosphatidylinositol 3-Kinase Inhibitors for Non-Hodgkin’s Lymphoma: Molecular Docking, Molecular Dynamics, and Density Functional Theory Studies on Gold Nanoparticles |
title_short | Design of Novel Phosphatidylinositol 3-Kinase Inhibitors for Non-Hodgkin’s Lymphoma: Molecular Docking, Molecular Dynamics, and Density Functional Theory Studies on Gold Nanoparticles |
title_sort | design of novel phosphatidylinositol 3-kinase inhibitors for non-hodgkin’s lymphoma: molecular docking, molecular dynamics, and density functional theory studies on gold nanoparticles |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10005307/ https://www.ncbi.nlm.nih.gov/pubmed/36903539 http://dx.doi.org/10.3390/molecules28052289 |
work_keys_str_mv | AT aliabdalrahimm designofnovelphosphatidylinositol3kinaseinhibitorsfornonhodgkinslymphomamoleculardockingmoleculardynamicsanddensityfunctionaltheorystudiesongoldnanoparticles AT makkialaaa designofnovelphosphatidylinositol3kinaseinhibitorsfornonhodgkinslymphomamoleculardockingmoleculardynamicsanddensityfunctionaltheorystudiesongoldnanoparticles AT ibraheemwalaa designofnovelphosphatidylinositol3kinaseinhibitorsfornonhodgkinslymphomamoleculardockingmoleculardynamicsanddensityfunctionaltheorystudiesongoldnanoparticles AT abdelrahmanmohammed designofnovelphosphatidylinositol3kinaseinhibitorsfornonhodgkinslymphomamoleculardockingmoleculardynamicsanddensityfunctionaltheorystudiesongoldnanoparticles AT osmanwadah designofnovelphosphatidylinositol3kinaseinhibitorsfornonhodgkinslymphomamoleculardockingmoleculardynamicsanddensityfunctionaltheorystudiesongoldnanoparticles AT sherifasmaae designofnovelphosphatidylinositol3kinaseinhibitorsfornonhodgkinslymphomamoleculardockingmoleculardynamicsanddensityfunctionaltheorystudiesongoldnanoparticles AT ashourahmed designofnovelphosphatidylinositol3kinaseinhibitorsfornonhodgkinslymphomamoleculardockingmoleculardynamicsanddensityfunctionaltheorystudiesongoldnanoparticles AT ibrahimsabrinrm designofnovelphosphatidylinositol3kinaseinhibitorsfornonhodgkinslymphomamoleculardockingmoleculardynamicsanddensityfunctionaltheorystudiesongoldnanoparticles AT ghazawikholoudf designofnovelphosphatidylinositol3kinaseinhibitorsfornonhodgkinslymphomamoleculardockingmoleculardynamicsanddensityfunctionaltheorystudiesongoldnanoparticles AT sammanwaada designofnovelphosphatidylinositol3kinaseinhibitorsfornonhodgkinslymphomamoleculardockingmoleculardynamicsanddensityfunctionaltheorystudiesongoldnanoparticles AT alzainabdulrahima designofnovelphosphatidylinositol3kinaseinhibitorsfornonhodgkinslymphomamoleculardockingmoleculardynamicsanddensityfunctionaltheorystudiesongoldnanoparticles |